ArticleERJ open research2024

Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial.

Ruchong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.